KR102444839B9 - 저분자 키토산을 포함하는 코로나바이러스 감염증 예방 또는 치료용 조성물 - Google Patents

저분자 키토산을 포함하는 코로나바이러스 감염증 예방 또는 치료용 조성물

Info

Publication number
KR102444839B9
KR102444839B9 KR1020210119259A KR20210119259A KR102444839B9 KR 102444839 B9 KR102444839 B9 KR 102444839B9 KR 1020210119259 A KR1020210119259 A KR 1020210119259A KR 20210119259 A KR20210119259 A KR 20210119259A KR 102444839 B9 KR102444839 B9 KR 102444839B9
Authority
KR
South Korea
Prior art keywords
preventing
composition
molecular weight
low molecular
weight chitosan
Prior art date
Application number
KR1020210119259A
Other languages
English (en)
Other versions
KR20220106912A (ko
KR102444839B1 (ko
Inventor
신용철
박철
류성원
이다겸
장동환
정지희
Original Assignee
아미코젠주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아미코젠주식회사 filed Critical 아미코젠주식회사
Priority to CN202111437836.4A priority Critical patent/CN114767707B/zh
Publication of KR20220106912A publication Critical patent/KR20220106912A/ko
Application granted granted Critical
Publication of KR102444839B1 publication Critical patent/KR102444839B1/ko
Publication of KR102444839B9 publication Critical patent/KR102444839B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/51—Polysaccharide
    • A23V2250/511—Chitin, chitosan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020210119259A 2021-01-22 2021-09-07 저분자 키토산을 포함하는 코로나바이러스 감염증 예방 또는 치료용 조성물 KR102444839B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111437836.4A CN114767707B (zh) 2021-01-22 2021-11-29 包含低分子壳聚糖的用于预防或治疗冠状病毒感染疾病的组合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020210009584 2021-01-22
KR20210009584 2021-01-22

Publications (3)

Publication Number Publication Date
KR20220106912A KR20220106912A (ko) 2022-08-01
KR102444839B1 KR102444839B1 (ko) 2022-09-19
KR102444839B9 true KR102444839B9 (ko) 2022-12-27

Family

ID=82844191

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210119259A KR102444839B1 (ko) 2021-01-22 2021-09-07 저분자 키토산을 포함하는 코로나바이러스 감염증 예방 또는 치료용 조성물

Country Status (1)

Country Link
KR (1) KR102444839B1 (ko)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008105934A2 (en) * 2006-09-22 2008-09-04 Oregon Biomedical Engineering Institute, Inc. Inactivation of toxic agents and pathogens using chitosan
WO2011142484A1 (ja) 2010-05-14 2011-11-17 株式会社日本触媒 ポリアルキレンイミンを含むウイルス感染症治療薬
CN111920945A (zh) 2020-09-22 2020-11-13 李伟宏 一种新型冠状病毒疫苗及其制备方法和应用

Also Published As

Publication number Publication date
KR20220106912A (ko) 2022-08-01
KR102444839B1 (ko) 2022-09-19

Similar Documents

Publication Publication Date Title
GB2480772B (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
EP4118115A4 (en) METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY
MY153900A (en) Antiviral composition comprising a sulfated polysaccharide
EP4143207A4 (en) VACCINE COMPOSITION FOR THE PREVENTION OR TREATMENT OF SARS-COV-2 INFECTION
MX2021002719A (es) Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos.
MX2012000136A (es) Composiciones que comprenden finafloxacina y metodos para tratar infecciones oftalmicas, oticas, o nasales.
WO2015110969A3 (en) Nitrogen containing compounds and their use as antibacterial agents
EP4121022A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION
EP2889034A3 (en) Compositions and methods of treatment comprising ceftaroline
SG11202105728YA (en) Method and compositions for treating coronavirus infection
EP4093758A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS
WO2010134827A9 (en) Extended acting oxygen generating composition for treating microbial infections
EP4103164A4 (en) COMPOUNDS FOR TREATING CORONAVIRUS INFECTIONS
WO2008036377A3 (en) Novel triclosan salts
KR102444839B9 (ko) 저분자 키토산을 포함하는 코로나바이러스 감염증 예방 또는 치료용 조성물
EP4121040A4 (en) METHOD AND COMPOSITIONS FOR TREATING, PREVENTING OR LIMITING THE APPEARANCE OF A VIRAL INFECTION
WO2011015514A3 (de) Haarbehandlungsmittel mit polyether-modifizierten organischen verbindungen und haarfestigenden polymeren
EP4017520A4 (en) CROTON-LECHLERI COMPOSITIONS FOR THE TREATMENT OF BLEEDING, WOUNDS AND INFECTION
EP4223303A4 (en) ANTIVIRAL AGENT FOR PREVENTING OR TREATING COVID-19 INFECTION
IL307872A (en) New compositions and methods for the treatment of corona virus infections
EP4146240A4 (en) METHODS OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION
WO2011056653A3 (en) Clonidine formulations having antimicrobial properties
EP4103192A4 (en) COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS
EP4121038A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTION AND RESPIRATORY COMPROMISE
WO2010105191A3 (en) Antimicrobial compositions and methods of use therefore

Legal Events

Date Code Title Description
AMND Amendment
X091 Application refused [patent]
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]